自发性蛛网膜下腔出血评分识别迟发性脑缺血与神经功能结局风险:受试者工作特征曲线分析比较
该单中心回顾性研究纳入2016年1月至2021年12月ICU收治的262例非创伤性蛛网膜下腔出血患者,评估HATCH与VASOGRADE评分识别3个月不良神经结局(GOS 1-3分)、院内死亡和迟发性脑缺血的判别能力,并与WFNS、改良Fisher、SOFA、APACHE II比较。HATCH与3个月不良结局独立相关(OR 1.61,95%CI 1.36-1.90),AUROC 0.83(95%CI 0.77-0.88),与APACHE II(0.84,95%CI 0.79-0.89)和SOFA(0.83,95%CI 0.77-0.88)相当。作者认为两评分预测表现良好,但未超越常规非特异性评分。
要点
- 262例非创伤性SAH患者中,31.3%(82例)发生迟发性脑缺血,29.8%(78例)院内死亡,51%(133例)3个月不良神经结局。
- HATCH与3个月不良结局独立相关:OR 1.61(95%CI 1.36-1.90)。
- HATCH预测3个月不良结局AUROC 0.83(95%CI 0.77-0.88),与APACHE II 0.84(95%CI 0.79-0.89)、SOFA 0.83(95%CI 0.77-0.88)相当。
- 作者结论:HATCH和VASOGRADE预测表现良好,但未优于常规使用的非特异性评分。
适用人群与场景
- ICU收治的非创伤性蛛网膜下腔出血患者,2016年1月至2021年12月单中心连续纳入。
诊断标准与关键阈值
- 不良神经结局定义为3个月时Glasgow结局量表评分1-3分。
- 迟发性脑缺血按原文定义观察,原文未列出具体诊断标准。
研究设计与关键结果
- 研究类型:单中心回顾性研究,样本量262例连续非创伤性SAH患者。
- 主要终点:HATCH预测3个月不良结局AUROC 0.83(95%CI 0.77-0.88);VASOGRADE预测DCI表现良好(原文未报告具体AUROC数值)。
- HATCH与3个月不良结局独立相关:OR 1.61(95%CI 1.36-1.90)。
- 对照评分:APACHE II预测不良结局AUROC 0.84(95%CI 0.79-0.89),SOFA AUROC 0.83(95%CI 0.77-0.88),与HATCH相当。
- 发生率:DCI 82例(31.3%),院内死亡78例(29.8%),3个月不良结局133例(51%)。
证据类型、等级与局限
- 证据类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HATCH和VASOGRADE评分预测UO或院内死亡及DCI表现良好,但未超越常规非特异性评分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Numerous grading scales were proposed for subarachnoid hemorrhage (SAH) to assess the likelihood of unfavorable neurological outcomes (UO) and the risk of delayed cerebral ischemia (DCI). We aimed to validate the Hemorrhage, Age, Treatment, Clinical Status, and Hydrocephalus (HATCH) score and the VASOGRADE, a simple grading scale for prediction of DCI after aneurysmal SAH.
METHODS: This was a retrospective single-center study of patients with nontraumatic SAH (January 2016 to December 2021) admitted to the intensive care unit. We performed a receiver operating characteristic (ROC) curve analysis to assess the discriminative ability of the HATCH and the VASOGRADE to identify patients who had UO at 3 months (defined as Glasgow Outcome Scale score of 1-3), hospital mortality, and DCI and compared their performance with the World Federation of Neurosurgical Surgeons, the modified Fisher, the Sequential Organ Failure Assessment, and the Acute Physiology and Chronic Health Evaluation II scales. We performed a multivariate logistic regression analysis to assess the association between HATCH and UO at 3 months and between VASOGRADE and DCI.
RESULTS: We included 262 consecutive patients with nontraumatic SAH. DCI was observed in 82 patients (31.3%), whereas 78 patients (29.8%) died during hospital stay and 133 patients (51%) had UO at 3 months. HATCH was independently associated with UO (odds ratio 1.61, 95% confidence interval [CI] 1.36-1.90) and had an area under the ROC curve (AUROC) of 0.83 (95% CI 0.77-0.88), comparable to the Acute Physiology and Chronic Health Evaluation II (AUROC 0.84, 95% CI 0.79-0.89) and Sequential Organ Failure Assessment (AUROC 0.83, 95% CI 0.77-0.88).
CONCLUSIONS: Hemorrhage, Age, Treatment, Clinical Status, and Hydrocephalus and VASOGARDE scores had a good performance to predict UO or in-hospital mortality and DCI, respectively; however, their performance did not outperform nonspecific routinely used scores.
参考来源
- Degrassi A, Conticello C, Njimi H, et al. Grading Scores for Identifying Patients at Risk of Delayed Cerebral Ischemia and Neurological Outcome in Spontaneous Subarachnoid Hemorrhage: A Comparison of Receiver Operator Curve Analysis. Neurocrit Care. 2025. PMID: 40293695. doi:10.1007/s12028-025-02270-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。